July 27, 2015 FDA: Guidance for Industry Duchenne Muscular Dystrophy Developing Drugs for Treatment Over the Spectrum of Disease
July 23, 2015 CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia July 23, 2015 CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia Austin, TX – 23 Ju
July 22, 2015 Critical Path Institute Establishes The Global Pediatric Clinical Trials Network Pre-Launch Consortium July 22, 2015 Critical Path Institute Establishes The Global Pediatric Clinical Trials Network Pre-Launch Con
July 14, 2015 The Predictive Safety Testing Consortium: Safety Biomarkers, Collaboration, and Qualification
July 8, 2015 Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates Offringa M, Davis JM, Turner MA, Ward R, Bax R, Maldonado S, Sinha V, McCune SK, Zajicek A, Daniel K. Benjamin J, Bucci-Rechtweg C
June 26, 2015 Patient-Centered Research To Support The Development Of The Symptoms Of Major Depressive Disorder Scale (SMDDS): Initial Qualitative Research
June 25, 2015 Critical Path Institute Announces Appointments of Peter Hutt, Alan Levin, and Paula Olsiewski To Its Board of Directors June 25, 2015 Critical Path Institute Announces Appointments of Peter Hutt, Alan Levin, and Paula Olsiewski To Its Board of Direc
June 15, 2015 Assessing the Landscape of Tools and Approaches for Novel Tuberculosis Regimen Development